Wall St slips as Apple, healthcare stocks drop


Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., September 28, 2016. REUTERS/Brendan McDermid

NEW YORK: Wall Street was lower in choppy trading late Thursday morning, pulled lower by Apple and healthcare stocks.

The S&P healthcare index fell 0.7%, marking the second straight day of decline as shares of Merck and Johnson & Johnson booked losses.

Apple fell 1.23% after Barclays cut its price target. The stock was the biggest drag on Wall Street.

Investors are awaiting Federal Reserve chair Janet Yellen’s speech in Washington for clues on the timing of the next interest rate hike.

“The markets are taking a step back after a couple of pretty good days,” said Paul Nolte, portfolio manager at Kingsview Asset Management in Chicago.

“It is the end of the quarter so there are people messing around with some positions.”

The three indexes have registered gains in the past two days.

At 11:01am. ET (1501 GMT), the Dow Jones Industrial Average was down 40.85 points, or 0.22%, at 18,298.39.

The S&P 500 was down 4.78 points, or 0.22%, at 2,166.59.

The Nasdaq Composite was down 22.79 points, or 0.43%, at 5,295.75.

Five of the 11 major S&P indexes were lower, with utilities  falling the most by 1.1%. The sector, which is sensitive to interest rates, is on track to mark its fifth day of losses in a row.

Kansas City Fed President and voting member Esther George told CNBC that it was time to move ahead with a rate hike, a stand that Atlanta Fed president Dennis Lockhart echoed.

Oil prices were up 0.4%, after Wednesday’s 6% rally, as investors questioned whether an Opec agreement to curb production would be enough to rebalance a heavily over-supplied market.

ConAgra was the top percentage gainer on the S&P, rising 7.3% after the company’s profit beat analysts’ estimate.

Intra-Cellular plunged 63.2% after the company said its schizophrenia drug did not show any clinically significant difference when compared with placebo.

Ebay rose 3% after Deutsche Bank upgraded the e-commerce platform’s rating to “buy” and raised its price target.

Declining issues outnumbered advancing ones on the NYSE by 1,667 to 1,156. On the Nasdaq, 1,625 issues fell and 995 advanced.

The S&P 500 index showed 19 new 52-week highs and one new lows, while the Nasdaq recorded 52 new highs and 20 new lows. - Reuters


Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

MAHB's 1Q24 traffic hits more than 90% recovery rate against 1Q19
IRDA's RM636bil investment goal to help propel Malaysia into top 30 global economies
DXN Holdings net profit for FY24 rises to RM310.99mil
Ringgit closes slightly lower against US dollar
Inta Bina bags RM170mil construction job
PETRONAS Gas commits to sustainability, announces total dividend of 72 sen per share
Crest Builder bags RM486mil condo job
Axis-REIT optimistic of maintaining its current performance for FY24
KIP REIT aims for RM2bil AUM
ATX Semiconductor to boost investment in Melaka to RM952mil

Others Also Read